Effect of Gamma Interferon on Phospholipid Hydrolysis and Fatty Acid Incorporation in L929 Cells Infected with Rickettsia Prowazekii
Overview
Authors
Affiliations
Treatment of Rickettsia prowazekii-infected L929 cells with gamma interferon (IFN-gamma) immediately after infection altered the lipid metabolism of the host cells as determined by measurement of phospholipid hydrolysis and oleic acid incorporation into phospholipids and neutral lipids. At 48 h postinfection, there was increased phospholipid hydrolysis in infected cultures relative to mock-infected cultures and a further increase in radiolabeled phospholipid hydrolysis in IFN-gamma-treated infected cultures. Oleic acid, the radiolabeled product of hydrolysis, was found in both the free fatty acid and neutral lipid fractions. None of the mock-infected cultures demonstrated increased hydrolysis of their radiolabeled phospholipids in response to treatment with IFN-gamma. Most of the radiolabeled oleic acid incorporated into cultures in the interval between 24 and 48 h after infection and IFN-gamma treatment was present in the phospholipid fraction. However, the neutral lipid fraction from the infected cultures that had been IFN-gamma treated was labeled to a greater extent than that from the untreated cultures. Thin-layer chromatographic analysis of the neutral lipid fractions from both the hydrolysis and incorporation experiments demonstrated that most of the radiolabel was in triglycerides. The infected cultures at 30 h were intact as assessed by the exclusion of trypan blue, but at 48 h postinfection in the IFN-gamma-treated infected cultures more than half of the cells were unable to exclude trypan blue. In no case did the mock-infected cells show substantial damage as a result of IFN-gamma treatment.
Turco J Trop Med Infect Dis. 2022; 7(8).
PMID: 36006255 PMC: 9415803. DOI: 10.3390/tropicalmed7080163.
Housley N, Winkler H, Audia J J Bacteriol. 2011; 193(18):4634-42.
PMID: 21764940 PMC: 3165714. DOI: 10.1128/JB.00141-11.
Winkler H, Day L, Daugherty R Infect Immun. 1994; 62(4):1457-9.
PMID: 8132353 PMC: 186302. DOI: 10.1128/iai.62.4.1457-1459.1994.
Turco J, Winkler H Infect Immun. 1994; 62(6):2568-74.
PMID: 7514579 PMC: 186546. DOI: 10.1128/iai.62.6.2568-2574.1994.